IFNA1, interferon alpha 1, 3439

N. diseases: 662; N. variants: 6
Disease: Advanced Melanoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4727838
Disease: Advanced Melanoma
Advanced Melanoma 		0.010 Biomarker disease BEFREE We explored the safety and preliminary antitumor activity of pembrolizumab combined with either ipilimumab or PEG-IFN in patients with advanced melanoma or RCC.<b>Experimental Design:</b> The phase Ib KEYNOTE-029 study (ClinicalTrials.gov, NCT02089685) included independent pembrolizumab plus reduced-dose ipilimumab and pembrolizumab plus PEG-IFN cohorts. 29358500 2018